Association cortex hypoperfusion in mild dementia with Lewy bodies: A potential indicator of cholinergic dysfunction?

Brain Imaging and Behavior

Volumn 5, Issue 1, 2011, Pages 25-35

  Fong, Tamara G ^a,b   Inouye, Sharon K ^a,b   Dai, Weiying ^b   Press, Daniel Z ^b   Alsop, David C ^b  

^a Hebrew Senior Life   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Arterial spin labeled perfusion MRI; Cholinesterase inhibitors; Dementia with Lewy bodies; Pharmacologic MRI

Indexed keywords

DONEPEZIL; PLACEBO;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ASSOCIATION CORTEX; BRAIN BLOOD FLOW; CHOLINERGIC ACTIVITY; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; FEMALE; FRONTAL CORTEX; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; OCCIPITAL CORTEX; PARIETAL CORTEX; PATHOPHYSIOLOGY; PERFUSION; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; SINGLE DRUG DOSE; SPIN LABELING; TEMPORAL CORTEX;

EID: 78751646786     PISSN: 19317557     EISSN: 19317565     Source Type: Journal    
DOI: 10.1007/s11682-010-9108-x     Document Type: Article

References (45)

1. Aarsland, D., Litvan, I., Salmon, D. P., Galasko, D., Wentzel-Larsen, T., & Larsen, J. (2003). Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry, 74, 1215-1220.
2. Ala, T. A., Hughes, L. F., Kyrouac, G. A., Ghobrial, M. W., & Elble, R. J. (2002). The mini-mental state exam may help in the differentiation of dementia with Lewy bodies and Alzheimer's disease. International Journal of Geriatric Psychiatry, 17(6), 503-509.
3. Albin, R. L., Minoshima, S., D'Amato, C. J., Frey, K. A., Kuhl, D. A., & Sima, A. A. (1996). Fluro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology, 47, 462-466.
4. Alsop, D. C., & Detre, J. A. (1998). Multisection cerebral blood flow MR imaging with continuous arterial spin labeling. Radiology, 208, 410-416.
5. Alsop, D. C., Casement, M., de Bazelaire, C., Fong, T., & Press, D. Z. (2008). Hippocampal hyperperfusion in Alzheimer's disease. Neuroimage, 42(4), 1267-1274.
6. Barker, W. W., Luis, C. A., Kashuba, A., Luis, M., Harwood, D. G., Loewenstein, D., et al. (2002). Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and Hippocampal sclerosis in the state of Florida brain bank. Alzheimer Disease and Associated Disorders, 16(4), 203-212.
7. Bohnen, N. I., Kaufer, D. I., Hendrickson, R., Ivanco, L. S., Lopresti, B. J., Koeppe, R. A., et al. (2005). Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by Donepezil treatment in Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry, 76(3), 315-319.
8. Braak, H., Del Tredici, K., Rub, U., de Vos, R. A., Jansen Steur, E. N., & Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of Aging, 24(2), 197-211.
9. Cavanna, A. E., & Trimble, M. R. (2006). The precuneus: a review of its functional anatomy and behavioural correlates. Brain, 129(Pt 3), 564-583.
10. Colloby, S. J., Fenwick, J. D., Williams, E. D., Paling, S. M., Lobotesis, K., Ballard, C., et al. (2002). A comparison of (99M)TC-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. European Journal of Nuclear Medicine and Molecular Imaging, 29(5), 615-622.
11. Dai, W., Garcia, D., de Bazelaire, C., & Alsop, D. C. (2008). Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magnetic Resonance in Medicine, 60(6), 1488-1497.
12. Defebvre, L. J., Leduc, V., Duhamel, A., Lecouffe, P., Pasquier, F., Lamy-Lhullier, C., et al. (1999). Technetium HMPAO spect study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease. Journal of Nuclear Medicine, 40(6), 956-962.
13. DeKosky, S. T., Ikonomovic, M. D., Styren, S. D., Beckett, L., Wisniewski, S., Bennett, D. A., et al. (2002). Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Annals of Neurology, 51, 145-155.
14. Detre, J. A., & Alsop, D. C. (1999). Perfusion magnetic resonance imaging with continuous arterial spin labeling: methods and clinical applications in the central nervous system. European Journal of Radiology, 30(2), 115-124.
15. Detre, J. A., Wang, J., Wang, Z., & Rao, H. (2009). Arterial spin-labeled perfusion MRI in basic and clinical neuroscience. Current Opinion in Neurology, 22(4), 348-355.
16. Ebmeier, K. P., Hunter, R., Curran, S. M., Dougal, N. J., Murray, C. L., Wyper, D. J., et al. (1992). Effects of a single dose of the acetylcholinesterase inhibitor velnacrine on recognition memory and regional cerebral blood flow in Alzheimer's disease. Psychopharmacology (Berl), 108(1-2), 103-109.
17. Firbank, M. J., Burn, D. J., McKeith, I. G., & O'Brien, J. T. (2005). Longitudinal study of cerebral blood flow spect in Parkinson's disease with dementia, and dementia with Lewy bodies. International Journal of Geriatric Psychiatry, 20(8), 776-782.
18. Floyd, T., Ratcliffe, S., Wang, J., Resch, B., & Detre, J. (2003). Precision of the casl-perfusion MRI technique for the measurement of cerebral blood flow in whole brain and vascular territories. Journal of Magnetic Resonance Imaging, 18, 649-655.
19. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). "Mini-mental-state": a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
20. Francis, P. T., & Perry, E. K. (2007). Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies. Movement Disorders, 22(Suppl 17), S351-S357.
21. Geaney, D. P., Soper, N., Shepstone, B. J., & Cowen, P. J. (1990). Effect of central cholinergic stimulation on regional cerebral blood flow in Alzheimer disease. Lancet, 335(8704), 1484-1487.
22. Imamura, T., Ishii, K., Hirono, N., & Al, E. (1999). Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies (DLB). NeuroReport, 10, 1903-1907.
23. Ishii, K., Imamura, T., Sasaki, M., Yamaji, S., Sakamoto, S., Kitagaki, H., et al. (1998). Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurology, 51(1), 125-130.
24. Ishii, K., Soma, T., Kono, A. K., Sofue, K., Miyamoto, N., Yoshikawa, T., et al. (2007). Comparison of regional brain volume and glucose metabolism between patients with mild dementia with Lewy bodies and those with mild Alzheimer's disease. Journal of Nuclear Medicine, 48(5), 704-711.
25. Kemp, P. M., Hoffmann, S. A., Tossici-Bolt, L., Fleming, J. S., & Holmes, C. (2007). Limitations of the HMPAO spect appearances of occipital lobe perfusion in the differential diagnosis of dementia with Lewy bodies. Nuclear Medicine Communications, 28(6), 451-456.
26. Klein, J. C., Eggers, C., Kalbe, E., Weisenbach, S., Hohmann, C., Vollmar, S., et al. (2010). Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. Neurology, 74(11), 885-892.
27. Lobotesis, K., Fenwick, J. D., Phipps, A., Ryman, A., Swann, A., Ballard, C., et al. (2001). Occipital hypoperfusion on spect in dementia with Lewy bodies but not ad. Neurology, 56(5), 643-649.
28. McKeith, I. G. (2002). Dementia with Lewy bodies. The British Journal of Psychiatry, 180, 144-147.
29. McKeith, I. G. (2006). Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Journal of Alzheimer's Disease, 9(3 Suppl), 417-423.
30. McKeith, I. G., Grace, J. B., Walker, Z., Byrne, E. J., Wilkinson, D., Stevens, T., et al. (2000). Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial. International Journal of Geriatric Psychiatry, 15(5), 387-392.
31. Mori, T., Ikeda, M., Fukuhara, R., Nestor, P. J., & Tanabe, H. (2006). Correlation of visual hallucinations with occipital RCBF changes by Donepezil in DLB. Neurology, 66(6), 935-937.
32. Palmqvist, S., Hansson, O., Minthon, L., & Londos, E. (2009). Practical suggestions on how to differentiate dementia with Lewy bodies from Alzheimer's disease with common cognitive tests. International Journal Geriatric Psychiatry.
33. Parkes, L. M., Rashid, W., Chard, D. T., & Tofts, P. S. (2004). Normal cerebral perfusion measurements using arterial spin labeling: reproducibility, stability, and age and gender effects. Magnetic Resonance in Medicine, 51(4), 736-743.
34. Pasquier, J., Michel, B. F., Brenot-Rossi, I., Hassan-Sebbag, N., Sauvan, R., & Gastaut, J. L. (2002). Value of (99M)TC-ECD Spet for the diagnosis of dementia with Lewy bodies. European Journal of Nuclear Medicine and Molecular Imaging, 29(10), 1342-1348.
35. Salmon, D. P., Galasko, D., & Hansen, L. A. (1996). Neuropsychological deficits associated with diffuse Lewy body disease. Brain and Cognition, 31, 148-165.
36. Sato, A., & Sato, Y. (1992). Regulation of regional cerebral blood flow by cholinergic fibers originating in the basal forebrain. Neuroscience Research, 14(4), 242-274.
37. Sato, A., Sato, Y., & Uchida, S. (2002). Regulation of cerebral cortical blood flow by the basal forebrain cholinergic fibers and aging. Autonomic Neuroscience, 96(1), 13-19.
38. Shimada, H., Hirano, S., Shinotoh, H., Aotsuka, A., Sato, K., Tanaka, N., et al. (2009). Mapping of brain acetylcholinesterase alterations in Lewy body disease by pet. Neurology, 73(4), 273-278.
39. Tierney, M. C., Fisher, R. H., Lewis, A. J., Zorzitto, M. L., Snow, W. G., Reid, D. W., et al. (1988). The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology, 38(3), 359-364.
40. Tiraboschi, P., Hansen, L. A., Alford, M., Merdes, A., Masliah, E., Thal, L. J., et al. (2002). Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease. Archives of General Psychiatry, 59(10), 946-951.
41. Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., et al. (2002). Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage, 15(1), 273-289.
42. Varma, A. R., Talbot, P. R., Snowden, J. S., Lloyd, J. J., Testa, H. J., & Neary, D. (1997). A 99MTC-HMPAO single-photon emission computed tomography study of Lewy body disease. Journal of Neurology, 244(6), 349-359.
43. Venneri, A., Shanks, M. F., Staff, R. T., Pestell, S. J., Forbes, K. E., Gemmell, H. G., et al. (2002). Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease. NeuroReport, 13(1), 83-87.
44. Whitwell, J. L., Weigand, S. D., Shiung, M. M., Boeve, B. F., Ferman, T. J., Smith, G. E., et al. (2007). Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. Brain, 130(Pt 3), 708-719.
45. Williams, D. S., Detre, J. A., Leigh, J. S., & Koretsky, A. P. (1992). Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proceedings of the National Academy of Sciences of the United States of America, 89(1), 212-216.